Search

Your search keyword '"Couper D"' showing total 480 results

Search Constraints

Start Over You searched for: Author "Couper D" Remove constraint Author: "Couper D"
480 results on '"Couper D"'

Search Results

1. Longitudinal Imaging-Based Clusters in Former Smokers of the COPD Cohort Associate with Clinical Characteristics: The SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)

2. Novel Respiratory Disability Score Predicts COPD Exacerbations and Mortality in the Spiromics Cohort

3. Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis

4. Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis [Corrigendum]

5. Association of Early COPD With Mortality and Respiratory Health Outcomes: The NHLBI Pooled Cohorts Study

6. Associations of Pre-pandemic Spirometry With COVID-19 Hospitalization or Death: The Collaborative Cohort of Cohorts for COVID-19 Research (C4R) Study

7. Dynamic Hyperinflation Measured by Cine Pulmonary MRI: The SPIROMICS Heart Failure Study

8. Proteomics of CT Emphysema Subtypes. The Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)

9. Effect of Smoking Cessation on COPD Exacerbations, Spirometry and Respiratory Symptoms in Spiromics

10. Cardiopulmonary Failure in Chronic Obstructive Pulmonary Disease (COPD): The Subpopulations and Intermediate Outcome Measures in COPD and Heart Failure Study (SPIROMICS HF)

11. Associations of COPD and Related Outcomes With COVID-19 Hospitalization or Death: The C4R, Copdgene, and Spiromics Studies

12. Genome-wide association analysis identifies six new loci associated with forced vital capacity

13. Excess Incidence of Coronary Heart Disease Mortality Attributable to Lower Lung Function

14. Linking Pathophysiology to Lung Pathology in Spiromics Using Respiratory Oscillometry (OSC) and High-resolution Computed Tomography (HRCT)

15. Association of Smoking History With COVID-19 Infection, Hospitalization and Death in the C4R Study

16. Association of Physical Performance Measures With Clinical Characteristics of COPD in SPIROMICS

17. Airway Epithelial Gene Expression Associated With Domains of Resilience in Smokers Without Airflow Obstruction

18. Non-cigarette Tobacco Products, AHRR Methylation, and All-cause Mortality in US Adults

19. Nebulizer use in tobacco-exposed SPIROMICS participants with or at risk of COPD

21. Associations of Pipe and Cigar Smoking with DNA Methylation Levels at the Aryl Hydrocarbon Receptor Repressor Gene

22. Association of Increased Chest CT Density (ICTD) with Clinical Features and Emphysema Progression in Ever Smokers

23. Impact of Marijuana on Progression of COPD in Middle-Aged and Older Ever Smokers of Tobacco: SPIROMICS Longitudinal Cohort Analysis

24. Eligibility for COPD Clinical Trials of Inhaled Triple Therapy: Analysis of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS)

25. Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption

27. Lung Structure and Risk of Sleep Apnea in SPIROMICS

28. Air Pollutant Exposure-by-Gene Interactions Associated with Emphysema, Lung Structure, and Lung Function in SPIROMICS

29. Clinical Implications of Low Absolute Blood Eosinophil Count in the SPIROMICS COPD Cohort

30. Cigar and Pipe Use Associated with Accelerated Lung Function Decline in the NHLBI Pooled Cohorts Study

31. Development and validation of an ankle brachial index risk model for the prediction of cardiovascular events

32. The effects of rare SERPINA1 variants on lung function and emphysema in SPIROMICS

35. Respiratory Mortality and Hospitalizations Associated with Preserved Ratio Impaired Spirometry (PRISm): The NHLBI Pooled Cohorts Study

36. Systemic Biomarkers of Lung Function and FEV1 Decline Across Multiple Cohorts

37. Insights from Mid-Expiratory Flow Rate (FEF25-75%) in Ever-Smokers with Preserved Lung Function in the Subpopulations and Intermediate Markers in COPD Study (SPIROMICS) Cohort

38. Plasma GDF-15 Levels Improve Risk Assessments for Severe COPD Outcomes

39. Smoking Reduction Among Current Smokers and Cause-Specific Mortality: The NHLBI Pooled Cohorts Study

40. Associations Between Metabolic Syndrome and Longitudinal Respiratory Outcomes: The NHLBI Pooled Cohorts Study

41. Lung Volumes Differences Across GOLD Stages of COPD in VA Electronic Health Records, COPDGene, and SPIROMICS

42. FEV1SVC Ratio Below 0.7 Is Associated with Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers with Normal Spirometry

43. Intermediate (CD14++ CD16+) Monocytes Correlate with Parametric Response Mapping of Functional Small Airways Disease: Spiromics Immunophenotyping Sub-Study

44. Associations Between Lung Function Impairment and Incident Heart Failure with Preserved Ejection Fraction (HFpEF): The NHLBI Pooled Cohorts Study

45. Significance of FEV3/FEV6 in Recognition of Early Airway Disease in Smokers at Risk of Development of COPD: Analysis of the SPIROMICS Cohort

47. Preserved Ratio Impaired Spirometry (PRISm) Is Associated with Increased Rates of Clinically Significant Spirometric Transitions in the NHLBI Pooled Cohorts

Catalog

Books, media, physical & digital resources